Total Payments
$731,257
2024 Payments
$62,874
Companies
53
Transactions
2,246
Medicare Patients
7,663
Medicare Billing
$680,444
Payment Breakdown by Category
Other$579,309 (79.2%)
Travel$60,933 (8.3%)
Consulting$52,132 (7.1%)
Food & Beverage$38,372 (5.2%)
Education$510.36 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $579,309 | 209 | 79.2% |
| Travel and Lodging | $60,933 | 112 | 8.3% |
| Consulting Fee | $52,132 | 20 | 7.1% |
| Food and Beverage | $38,372 | 1,886 | 5.2% |
| Education | $510.36 | 19 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $273,181 | 608 | $0 (2024) |
| Amgen Inc. | $203,467 | 198 | $0 (2024) |
| Celgene Corporation | $170,543 | 202 | $0 (2019) |
| E.R. Squibb & Sons, L.L.C. | $34,977 | 83 | $0 (2024) |
| Arcutis Biotherapeutics, Inc. | $27,107 | 32 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $3,154 | 28 | $0 (2023) |
| Janssen Biotech, Inc. | $2,955 | 232 | $0 (2024) |
| Journey Medical Corporation | $2,147 | 99 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $1,516 | 74 | $0 (2024) |
| Lilly USA, LLC | $1,382 | 86 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $62,874 | 285 | Amgen Inc. ($31,894) |
| 2023 | $86,512 | 312 | Amgen Inc. ($48,499) |
| 2022 | $59,866 | 309 | Amgen Inc. ($55,885) |
| 2021 | $49,565 | 211 | Amgen Inc. ($29,022) |
| 2020 | $63,508 | 147 | AbbVie Inc. ($35,593) |
| 2019 | $170,188 | 320 | AbbVie, Inc. ($85,915) |
| 2018 | $153,376 | 304 | Celgene Corporation ($99,760) |
| 2017 | $85,368 | 358 | AbbVie, Inc. ($81,697) |
All Payment Transactions
2,246 individual payment records from CMS Open Payments — Page 1 of 90
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $16.64 | General |
| Category: Immunology | ||||||
| 12/20/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $9.45 | General |
| Category: Immunology | ||||||
| 12/19/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | — | Food and Beverage | In-kind items and services | $77.73 | General |
| 12/18/2024 | PFIZER INC. | CIBINQO (Drug) | Food and Beverage | In-kind items and services | $14.60 | General |
| Category: Inflammation & Immunology | ||||||
| 12/18/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $7.54 | General |
| Category: Immunology | ||||||
| 12/17/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $24.88 | General |
| Category: Immunology | ||||||
| 12/17/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $14.28 | General |
| Category: DERMATOLOGY | ||||||
| 12/16/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $1.17 | General |
| Category: Inflammation | ||||||
| 12/10/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $7.44 | General |
| Category: Immunology | ||||||
| 12/04/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $21.30 | General |
| Category: DERMATOLOGY | ||||||
| 12/04/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $6.81 | General |
| Category: Immunology | ||||||
| 12/02/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $28.22 | General |
| 11/27/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $11.42 | General |
| Category: Dermatology | ||||||
| 11/26/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $11.54 | General |
| Category: DERMATOLOGY | ||||||
| 11/25/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $20.54 | General |
| Category: Inflammation | ||||||
| 11/22/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $23.07 | General |
| Category: Dermatology | ||||||
| 11/21/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $12.23 | General |
| Category: IMMUNOLOGY | ||||||
| 11/20/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Consulting Fee | Cash or cash equivalent | $3,375.00 | General |
| Category: Dermatology | ||||||
| 11/19/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $16.69 | General |
| Category: Immunology | ||||||
| 11/18/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $29.97 | General |
| Category: IMMUNOLOGY | ||||||
| 11/18/2024 | Lilly USA, LLC | EBGLYSS (Drug) | Food and Beverage | In-kind items and services | $15.90 | General |
| Category: Immunology | ||||||
| 11/14/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Winlevi (Drug) | Food and Beverage | In-kind items and services | $24.66 | General |
| Category: Dermatology | ||||||
| 11/14/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $16.56 | General |
| Category: Dermatology | ||||||
| 11/14/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $4.72 | General |
| Category: IMMUNOLOGY | ||||||
| 11/12/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Travel and Lodging | In-kind items and services | $636.25 | General |
| Category: Dermatology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 23 | 1,712 | 19,031 | $485,297 | $168,786 |
| 2022 | 22 | 1,810 | 13,787 | $482,113 | $158,099 |
| 2021 | 24 | 1,766 | 14,083 | $475,965 | $166,213 |
| 2020 | 22 | 2,375 | 23,028 | $406,764 | $187,345 |
Total Patients
7,663
Total Services
69,929
Medicare Billing
$680,444
Procedure Codes
91
All Medicare Procedures & Services
91 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 504 | 630 | $110,216 | $36,411 | 33.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 202 | 274 | $67,936 | $22,147 | 32.6% |
| J7345 | Aminolevulinic acid hcl for topical administration, 10% gel, 10 mg | Office | 2023 | 45 | 16,600 | $54,920 | $21,529 | 39.2% |
| 96574 | Application of light with debridement to destroy precancer skin growth | Office | 2023 | 49 | 93 | $49,995 | $19,591 | 39.2% |
| J7308 | Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg) | Office | 2023 | 19 | 39 | $30,491 | $11,947 | 39.2% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 230 | 277 | $35,896 | $11,792 | 32.8% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 67 | 68 | $14,865 | $4,879 | 32.8% |
| 96573 | Application of light by qualified health care professional to destroy precancer skin growth | Office | 2023 | 20 | 28 | $12,266 | $4,667 | 38.0% |
| 11302 | Shaving of skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 43 | 54 | $14,329 | $4,665 | 32.6% |
| 11301 | Shaving of skin growth of body, arms, or legs, 0.6-1.0 cm | Office | 2023 | 43 | 52 | $12,259 | $3,723 | 30.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 45 | 45 | $9,773 | $3,145 | 32.2% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 50 | 51 | $9,973 | $3,124 | 31.3% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2023 | 20 | 23 | $7,950 | $2,751 | 34.6% |
| 11311 | Shaving of skin growth of face, ears, eyelids, nose, lips, or mouth, 0.6-1.0 cm | Office | 2023 | 29 | 30 | $7,959 | $2,715 | 34.1% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 165 | 569 | $7,282 | $2,703 | 37.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 21 | 21 | $6,799 | $2,513 | 37.0% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 60 | 64 | $6,990 | $2,436 | 34.9% |
| 11310 | Shaving of skin growth of face, ears, eyelids, nose, lips, or mouth, 0.5 cm or less | Office | 2023 | 25 | 33 | $7,433 | $2,261 | 30.4% |
| 11312 | Shaving of skin growth of face, ears, eyelids, nose, lips, or mouth, 1.1-2.0 cm | Office | 2023 | 13 | 13 | $3,930 | $1,461 | 37.2% |
| 11104 | Punch biopsy, first skin growth | Office | 2023 | 15 | 17 | $4,112 | $1,424 | 34.6% |
| 11300 | Shaving of skin growth of body, arms, or legs, 0.5 cm or less | Office | 2023 | 19 | 21 | $4,106 | $1,294 | 31.5% |
| 11306 | Shaving of skin growth of scalp, neck, hands, feet, or genitals, 0.6-1.0 cm | Office | 2023 | 17 | 18 | $4,281 | $1,160 | 27.1% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 11 | 11 | $1,537 | $449.36 | 29.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 600 | 800 | $142,416 | $44,290 | 31.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 140 | 202 | $50,783 | $16,587 | 32.7% |
About Dr. Mark Seraly, M.D
Dr. Mark Seraly, M.D is a Dermatology healthcare provider based in Mc Murray, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/27/2005. The National Provider Identifier (NPI) number assigned to this provider is 1912907452.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mark Seraly, M.D has received a total of $731,257 in payments from pharmaceutical and medical device companies, with $62,874 received in 2024. These payments were reported across 2,246 transactions from 53 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($579,309).
As a Medicare-enrolled provider, Seraly has provided services to 7,663 Medicare beneficiaries, totaling 69,929 services with total Medicare billing of $680,444. Data is available for 4 years (2020–2023), covering 91 distinct procedure/service records.
Ad
Practice Information
- Specialty Dermatology
- Other Specialties Procedural Dermatology
- Location Mc Murray, PA
- Active Since 07/27/2005
- Last Updated 07/12/2024
- Taxonomy Code 207N00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1912907452
Products in Payments
- Otezla (Drug) $361,584
- Humira (Biological) $148,319
- SKYRIZI (Biological) $50,592
- Skyrizi (Biological) $35,497
- Sotyktu (Drug) $30,141
- Zoryve (Drug) $22,175
- Otezla (Biological) $11,214
- DUPIXENT (Biological) $3,893
- TREMFYA (Drug) $2,210
- RINVOQ (Biological) $1,354
- TALTZ (Drug) $1,309
- COSENTYX (Biological) $1,067
- EUCRISA (Drug) $821.74
- Enbrel (Biological) $716.79
- Tremfya (Drug) $560.95
- REMICADE (Biological) $482.14
- VTAMA (Drug) $456.74
- AMELUZ (Drug) $447.01
- Exelderm (Drug) $408.70
- OPZELURA (Drug) $407.22
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.